Tag Archives: type 2 diabetes medications

Exenatide in Combination Therapy. Type 2 Diabetes Treatment

 Bydureon exenatide or Byetta exenatide are novel GLP-1 (Glucagon-like Peptide-1) incretin mimetic hormone FDA approved for use in type 2 diabetes treatment. Byetta (exenatide) and Bydureon (exenatide) are used in combination therapy to improve blood glucose control in people diagnosed with type 2 diabetes who are taking sulfonylureas, a metformin, a thiazolidinediones (TZDs), a combination of metformin and thiazolidinediones, or a combination of sulfonylureas and metformin.

» Read more

Type 2 Diabetes Medications. Sulfonylureas Medications for Type 2 Diabetes Treatment

Sulfonylureas medications for Type 2 diabetes treatment were first type two medications marketed in 1957 for type 2 diabetes treatment. The first generation sulfonylureas which are tolinase, diabinese, and orinase, can improve hyperglycemia but potential drug interactions resulting in hypoglycemia make these type 2 diabetes medications less attractive than the following second generation of sulfonylureas drugs. Glipizide and glyburide drugs were introduced in 1984, with glimepiride followed in 1996.
» Read more